MRI features as a helpful tool to predict the molecular subgroups of medulloblastoma: state of the art

Medulloblastoma is the most common malignant pediatric brain tumor. Medulloblastoma should not be viewed as a single disease, but as a heterogeneous mixture of various subgroups with distinct characteristics. Based on genomic profiles, four distinct molecular subgroups are identified: Wingless (WNT), Sonic Hedgehog (SHH), Group 3 and Group 4. Each of these subgroups are associated with specific genetic aberrations, typical age of onset as well as survival prognosis. Magnetic resonance imaging (MRI) is performed for all patients with brain tumors, and has a key role in the diagnosis, surgical guidance and follow up of patients with medulloblastoma. Several studies indicate MRI as a promising tool for early detection of medulloblastoma subgroups. The early identification of the subgroup can influence the extent of surgical resection, radiotherapy and chemotherapy targeted treatments. In this article, we review the state of the art in MRI-facilitated medulloblastoma subgrouping, with a summary of the main MRI features in medulloblastoma and a brief discussion on molecular characterization of medulloblastoma subgroups. The main focus of the article is MRI features that correlate with medulloblastoma subtypes, as well as features suggestive of molecular subgroups. Finally, we briefly discuss the latest trends in MRI studies and latest developments in molecular characterization.

[1]  F. Gilles,et al.  Molecular subgroups of medulloblastoma identification using noninvasive magnetic resonance spectroscopy. , 2015, Neuro-oncology.

[2]  Roland Eils,et al.  Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition. , 2014, Cancer cell.

[3]  S. Higano,et al.  Minimum apparent diffusion coefficient is significantly correlated with cellularity in medulloblastomas , 2009, Neurological research.

[4]  W. Whitehead,et al.  Implications of Tumor Location on Subtypes of Medulloblastoma , 2013, Pediatric blood & cancer.

[5]  D. Zwijnenburg,et al.  OTX2 sustains a bivalent-like state of OTX2-bound promoters in medulloblastoma by maintaining their H3K27me3 levels , 2012, Acta Neuropathologica.

[6]  Massimiliano Valeriani,et al.  Metastatic Group 3 Medulloblastoma in a Patient With Tuberous Sclerosis Complex: Case Description and Molecular Characterization of the Tumor , 2016, Pediatric blood & cancer.

[7]  Matthew J. Betts,et al.  Dissecting the genomic complexity underlying medulloblastoma , 2012, Nature.

[8]  D. Mikulis,et al.  Diagnostic value of peritumoral minimum apparent diffusion coefficient for differentiation of glioblastoma multiforme from solitary metastatic lesions. , 2011, AJR. American journal of roentgenology.

[9]  D. Cochrane,et al.  Diffusion-weighted imaging and pathological correlation in pediatric medulloblastomas—“They are not always restricted!” , 2011, Child's Nervous System.

[10]  E. Miele,et al.  Anomalous vascularization in a Wnt medulloblastoma: a case report , 2016, BMC Neurology.

[11]  J. Barnholtz-Sloan,et al.  CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. , 2013, Neuro-oncology.

[12]  F. Gilles,et al.  Untreated pediatric primitive neuroectodermal tumor in vivo: quantitation of taurine with MR spectroscopy. , 2005, Radiology.

[13]  Toshihiro Kumabe,et al.  Cytogenetic prognostication within medulloblastoma subgroups. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  A. Albright.  Pediatric brain tumors. , 1993, CA: a cancer journal for clinicians.

[15]  P. Febbo,et al.  An animal model of MYC-driven medulloblastoma. , 2012, Cancer cell.

[16]  David T. W. Jones,et al.  Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis. , 2013, The Lancet. Oncology.

[17]  M. Roussel,et al.  A mouse model of the most aggressive subgroup of human medulloblastoma. , 2012, Cancer cell.

[18]  G. Riggins,et al.  OTX2 represses myogenic and neuronal differentiation in medulloblastoma cells. , 2012, Cancer research.

[19]  Patrick Granton,et al.  Radiomics: extracting more information from medical images using advanced feature analysis. , 2012, European journal of cancer.

[20]  W. Chu,et al.  Paediatric intra-axial posterior fossa tumours: pictorial review , 2012, Postgraduate Medical Journal.

[21]  F. Gilles,et al.  Quantitative short echo time 1H-MR spectroscopy of untreated pediatric brain tumors: preoperative diagnosis and characterization. , 2006, AJNR. American journal of neuroradiology.

[22]  Roland Eils,et al.  The whole-genome landscape of medulloblastoma subtypes , 2017, Nature.

[23]  M. Kool,et al.  Sonic hedgehog-associated medulloblastoma arising from the cochlear nuclei of the brainstem , 2012, Acta Neuropathologica.

[24]  Scott L. Pomeroy,et al.  Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples , 2011, Acta Neuropathologica.

[25]  Hendrik Witt,et al.  Medulloblastoma comprises four distinct molecular variants. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  K. Yeom,et al.  Distinctive MRI features of pediatric medulloblastoma subtypes. , 2013, AJR. American journal of roentgenology.

[27]  A. Osborn,et al.  Magnetic resonance imaging spectrum of medulloblastoma , 2011, Neuroradiology.

[28]  P. Burger,et al.  Medulloblastoma with extensive nodularity: a variant with favorable prognosis. , 1999, Journal of neurosurgery.

[29]  R. Barnard,et al.  The classification of tumours of the central nervous system. , 1982, Neuropathology and applied neurobiology.

[30]  I. Screpanti,et al.  Characterization of medulloblastoma in Fanconi Anemia: a novel mutation in the BRCA2 gene and SHH molecular subgroup , 2015, Biomarker Research.

[31]  P. Robertson,et al.  Incidence and severity of postoperative cerebellar mutism syndrome in children with medulloblastoma: a prospective study by the Children's Oncology Group. , 2006, Journal of neurosurgery.

[32]  Yiai Tong,et al.  Subtypes of medulloblastoma have distinct developmental origins , 2010, Nature.

[33]  Naoki Kagawa,et al.  Prognostic Value of Medulloblastoma Extent of Resection After Accounting for Molecular Subgroup: An Integrated Clinical and Molecular Analysis , 2016, The Lancet. Oncology.

[34]  T. Miyashita,et al.  Gorlin syndrome (nevoid basal cell carcinoma syndrome): Update and literature review , 2014, Pediatrics international : official journal of the Japan Pediatric Society.

[35]  T. Fan,et al.  The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type. , 2012, Cell metabolism.

[36]  Chunde Li,et al.  Distinctive localization and MRI features correlate of molecular subgroups in adult medulloblastoma , 2017, Journal of Neuro-Oncology.

[37]  D. Ellison,et al.  MR Imaging Characteristics of Wingless-Type–Subgroup Pediatric Medulloblastoma , 2015, American Journal of Neuroradiology.

[38]  H. Kinouchi,et al.  Medulloblastoma with extensive nodularity: single photon emission CT study with iodine-123 metaiodobenzylguanidine. , 2002, AJNR. American journal of neuroradiology.

[39]  A. Choudhri,et al.  Pediatric Cerebellar Tumors: Emerging Imaging Techniques and Advances in Understanding of Genetic Features. , 2016, Magnetic resonance imaging clinics of North America.

[40]  Elaine R. Mardis,et al.  Novel mutations target distinct subgroups of medulloblastoma , 2012, Nature.

[41]  R C McKinstry,et al.  Evaluating pediatric brain tumor cellularity with diffusion-tensor imaging. , 2001, AJR. American journal of roentgenology.

[42]  晏 小林,et al.  脳内出血で発症した転移性extraskeletal myxoid chondrosarcomaの1例 , 2008 .

[43]  A. Panigrahy,et al.  MR Spectroscopy of Pediatric Brain Disorders , 2012 .

[44]  B. Scheithauer,et al.  The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.

[45]  T. Young Poussaint,et al.  Posterior Fossa Tumors. , 2017, Neuroimaging clinics of North America.

[46]  Deena M. A. Gendoo,et al.  Medulloblastoma subgroups remain stable across primary and metastatic compartments , 2015, Acta Neuropathologica.

[47]  J. Mesirov,et al.  Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[48]  K. Yeom,et al.  MRI Surrogates for Molecular Subgroups of Medulloblastoma , 2014, American Journal of Neuroradiology.

[49]  E. Rushing,et al.  From the archives of the AFIP: medulloblastoma: a comprehensive review with radiologic-pathologic correlation. , 2003, Radiographics : a review publication of the Radiological Society of North America, Inc.

[50]  Scott L. Pomeroy,et al.  Medulloblastomics: the end of the beginning , 2012, Nature Reviews Cancer.

[51]  M. Kool,et al.  Subgroup-specific localization of human medulloblastoma based on pre-operative MRI , 2014, Acta Neuropathologica.

[52]  K. Kono,et al.  The role of diffusion-weighted imaging in patients with brain tumors. , 2001, AJNR. American journal of neuroradiology.

[53]  Jill S. Barnholtz-Sloan,et al.  CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012 , 2015, Neuro-oncology.

[54]  M. Krieger,et al.  Symptoms before and after Posterior Fossa Surgery in Pediatric Patients , 2012, Pediatric Neurosurgery.

[55]  Scott L. Pomeroy,et al.  Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas , 2012, Acta Neuropathologica.

[56]  Arie Perry,et al.  Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups , 2011, Acta Neuropathologica.

[57]  A. Goldenberg,et al.  Intertumoral Heterogeneity within Medulloblastoma Subgroups. , 2017, Cancer cell.

[58]  Claire L Weston,et al.  beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[59]  G. Gatta,et al.  Childhood medulloblastoma. , 2011, Critical reviews in oncology/hematology.

[60]  D. Ellison,et al.  The origins of medulloblastoma subtypes. , 2008, Annual review of pathology.

[61]  Daniel L. A. Camacho,et al.  Apparent diffusion coefficients for differentiation of cerebellar tumors in children. , 2006, AJNR. American journal of neuroradiology.

[62]  G. Reifenberger,et al.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary , 2016, Acta Neuropathologica.

[63]  J. Haselgrove,et al.  Diffusion-weighted imaging and fluid attenuated inversion recovery imaging in the evaluation of primitive neuroectodermal tumors , 2001, Neuroradiology.

[64]  Paul A. Northcott,et al.  Pediatric and adult sonic hedgehog medulloblastomas are clinically and molecularly distinct , 2011, Acta Neuropathologica.

[65]  Scott L. Pomeroy,et al.  Molecular subgroups of medulloblastoma: the current consensus , 2011, Acta Neuropathologica.

[66]  K. Yeom,et al.  The role of angiogenesis in Group 3 medulloblastoma pathogenesis and survival , 2017, Neuro-oncology.

[67]  Susan M. Chang,et al.  Response assessment in medulloblastoma and leptomeningeal seeding tumors: recommendations from the Response Assessment in Pediatric Neuro-Oncology committee , 2018, Neuro-oncology.

[68]  K. Yeom,et al.  Radiomics in Brain Tumor: Image Assessment, Quantitative Feature Descriptors, and Machine-Learning Approaches , 2017, American Journal of Neuroradiology.

[69]  David T. W. Jones,et al.  Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[70]  S. Meyers,et al.  MR imaging features of medulloblastomas. , 1992, AJR. American journal of roentgenology.

[71]  C. Lim,et al.  MRI features in children with desmoplastic medulloblastoma , 2012, Journal of Clinical Neuroscience.